"10.1371_journal.pone.0060382","plos one","2013-03-29T00:00:00Z","Lina Chiuccariello; Isabelle Boileau; Mihail Guranda; Pablo M Rusjan; Alan A Wilson; Laurie Zawertailo; Sylvain Houle; Usoa Busto; Bernard Le Foll","Translational Addiction Research Laboratory, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Addiction Imaging Research Group, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Research Imaging Center, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Clinical Neuroscience Program, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Alcohol Research and Treatment Clinic, Centre for Addiction and Mental Health (CAMH), Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, Canada; Faculty of Pharmacy, University of Toronto, Toronto, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Canada","Conceived and designed the experiments: LC BLF LZ UB AW SH IB. Performed the experiments: LC MG. Analyzed the data: LC IB PR. Contributed reagents/materials/analysis tools: AW SH. Wrote the paper: LC IB BLF.","Dr. Le Foll has received operating grant funding for other studies from Pfizer and is a consultant for Richter Pharmaceuticals, Lundbeck, Mylan, Ethypharm and Pfizer. Drs. Wilson and Houle have received operating grant funding for other studies from Eli Lilly, Lundbeck, and SK Life Science in the past 12 months. None of these companies participated in the design or execution of this study or writing the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2013","03","Lina Chiuccariello","LC",9,TRUE,7,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
